GO:0016239 positive regulation of macroautophagy: Activation Mechanisms, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0016239 describes any process that activates or increases the rate of macroautophagy, the bulk degradation of cytosolic components in lysosomes/vacuoles.
Positive regulation of macroautophagy is triggered by nutrient depletion, stress, and signaling cues that converge on the ULK1/ATG13/FIP200 complex and downstream ATG proteins.
Key positive regulators include TXNIP, HMBOX1, COPS3-FOXO3, RUBCNL/PACER, and SnRK1, which modulate autophagy initiation, autophagosome maturation, or feedback loops.
Dysregulated macroautophagy activation contributes to steatohepatitis, cancer chemoresistance, psoriasis, and neurodegeneration.
CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of autophagy regulators in disease.
EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate autophagy research.

Description

Macroautophagy is a conserved catabolic process that delivers cytoplasmic cargo to lysosomes for degradation and recycling. The Gene Ontology term GO:0016239, positive regulation of macroautophagy, encompasses all molecular events that activate or upregulate this pathway in response to nutrient depletion, stress, or developmental signals. This term is critical for understanding how cells maintain homeostasis and adapt to metabolic challenges. Dysregulation of macroautophagy activation is implicated in a wide range of diseases, including cancer, metabolic disorders, and inflammatory conditions. Researchers studying this process need reliable tools to manipulate and measure autophagy flux, making GO:0016239 a central node in both basic and translational research.

positive regulation of macroautophagy At A Glance

GO ID GO:0016239
GO term positive regulation of macroautophagy
Ontology biological_process
Synonym activation of macroautophagy; stimulation of macroautophagy; upregulation of macroautophagy; positive regulation of starvation-induced autophagy
Major function Activates or increases the rate of macroautophagy, the bulk degradation of cytosolic components in lysosomes/vacuoles
Related processes Autophagy initiation, autophagosome maturation, lysosomal degradation, nutrient sensing
Key regulators ULK1 complex, ATG proteins, TXNIP, HMBOX1, COPS3-FOXO3, RUBCNL/PACER, SnRK1
Disease relevance Cancer, steatohepatitis, psoriasis, neurodegeneration, chemoresistance

What Is GO:0016239?

GO:0016239, positive regulation of macroautophagy, is defined as any process that activates or increases the rate of macroautophagy, bringing cytosolic macromolecules to the vacuole or lysosome for degradation. This includes recognition of nutrient depletion and subsequent signaling events that stimulate autophagosome formation and maturation.

Why Is positive regulation of macroautophagy Important in Cell Biology?

Positive regulation of macroautophagy is essential for cellular adaptation to stress, nutrient deprivation, and pathogen invasion. It plays a dual role in disease: promoting survival in cancer cells under metabolic stress, while also protecting against neurodegeneration and metabolic disorders. Understanding the molecular mechanisms that activate macroautophagy can reveal therapeutic targets for a broad spectrum of human diseases.
Maintains energy homeostasis during starvation by recycling amino acids and lipids.
Protects against steatohepatitis by enhancing fatty acid oxidation and reducing lipid accumulation.
Contributes to chemoresistance in colorectal cancer and osteosarcoma by promoting cell survival.
Modulates inflammatory responses in psoriasis through unconventional secretion of HMGB1.
Regulates neuronal survival and is implicated in Parkinson's disease via LRRK2.
Controls plant stress responses through SnRK1 feedback regulation.
Influences apoptosis and necroptosis through RUBCNL/PACER-mediated repression of RIPK1.
Serves as a target for therapeutic intervention in metabolic and neoplastic diseases.

What Happens During positive regulation of macroautophagy?

Initiation and ULK1 Complex Activation
In simple terms: The cell senses low nutrients and flips a switch to start autophagy.
Positive regulation of macroautophagy begins with the activation of the ULK1/ATG13/FIP200 complex, which is inhibited by mTORC1 under nutrient-rich conditions. Upon nutrient depletion or stress, mTORC1 is inhibited, allowing ULK1 to autophosphorylate and initiate autophagosome formation. TXNIP has been shown to promote autophagy initiation and fatty acid oxidation in steatohepatitis.
Phagophore Nucleation and ATG Recruitment
In simple terms: A membrane sac forms and recruits proteins that build the autophagosome.
Activated ULK1 phosphorylates downstream targets including ATG13 and FIP200, leading to the recruitment of the class III PI3K complex (VPS34, Beclin-1, ATG14) that generates phosphatidylinositol-3-phosphate for phagophore nucleation. HMBOX1 has been shown to reverse autophagy-mediated 5-fluorouracil resistance by promoting HACE1-induced ubiquitination and degradation of ATG5, thereby limiting autophagosome elongation.
Autophagosome Elongation and Maturation
In simple terms: The membrane expands and closes to form a double-membrane vesicle.
Two ubiquitin-like conjugation systems, ATG12-ATG5-ATG16L1 and LC3-PE, are essential for autophagosome elongation and closure. Positive regulation of macroautophagy increases the lipidation of LC3, a hallmark of autophagosome formation. RUBCNL/PACER has been identified as a positive regulator that represses RIPK1 kinase-dependent apoptosis and necroptosis, thereby favoring autophagic cell survival.
Fusion with Lysosome and Degradation
In simple terms: The autophagosome merges with the lysosome to digest its contents.
Mature autophagosomes fuse with lysosomes to form autolysosomes, where acid hydrolases degrade the cargo. Positive regulation of macroautophagy enhances this fusion step, ensuring efficient turnover of cytosolic macromolecules. In plants, SnRK1 signaling is positively regulated by autophagy, creating a feedback loop that sustains energy homeostasis under stress.
Feedback Regulation and Signaling Crosstalk
In simple terms: Autophagy can turn itself up or down through feedback loops.
Positive regulation of macroautophagy is subject to feedback control. The COPS3-FOXO3 positive feedback loop promotes autophagy and cisplatin resistance in osteosarcoma, illustrating how autophagy activation can be amplified in cancer cells. Similarly, SnRK1 signaling in plants is sustained by autophagy, demonstrating evolutionary conservation of feedback regulation.

Key Genes Involved in GO:0016239 positive regulation of macroautophagy

The following genes and proteins are central to the positive regulation of macroautophagy, as supported by published literature.
GeneMajor RoleResearch Relevance
TXNIPPromotes autophagy initiation and fatty acid oxidationSteatohepatitis, metabolic disorders
HMBOX1Promotes HACE1-induced ubiquitination and degradation of ATG5Colorectal cancer chemoresistance
COPS3Part of positive feedback loop with FOXO3 to regulate autophagyOsteosarcoma cisplatin resistance
FOXO3Transcription factor that upregulates autophagy genesCancer chemoresistance, longevity
RUBCNL/PACERRepresses RIPK1-dependent apoptosis and necroptosisCell survival, inflammation
HMGB1Unconventional secretion mediated by autophagyPsoriatic skin inflammation
LRRK2Modulates autophagy and lysosomal functionParkinson's disease
SnRK1Energy sensor that is positively regulated by autophagyPlant stress responses
ATG5Essential for autophagosome elongationAutophagy core machinery
ATG13ULK1 complex componentAutophagy initiation
FIP200ULK1 complex componentAutophagy initiation
ULK1Serine/threonine kinase that initiates autophagyAutophagy initiation
Beclin-1PI3K complex componentAutophagosome nucleation
VPS34PI3K that generates PI3P for nucleationAutophagosome nucleation
LC3Ubiquitin-like protein conjugated to PEAutophagosome marker
HACE1E3 ubiquitin ligase that targets ATG5Colorectal cancer
RIPK1Kinase regulated by RUBCNL/PACERApoptosis and necroptosis

How Is positive regulation of macroautophagy Regulated?

Positive regulation of macroautophagy is controlled by multiple signaling pathways. The mTORC1 pathway is a major negative regulator; its inhibition by nutrient depletion or rapamycin activates autophagy. AMPK activates ULK1 under low energy conditions. TXNIP promotes autophagy and fatty acid oxidation in steatohepatitis. The COPS3-FOXO3 feedback loop amplifies autophagy in osteosarcoma. RUBCNL/PACER modulates the balance between autophagy and cell death. In plants, SnRK1 signaling is positively regulated by autophagy, forming a feedback loop.

positive regulation of macroautophagy and Human Disease

GeneDisease / BiologyPotential Experimental Model
TXNIPSteatohepatitisKnockout mouse, hepatocyte overexpression
HMBOX1Colorectal cancer chemoresistanceKnockout cell lines, xenograft
COPS3Osteosarcoma cisplatin resistanceKnockdown, overexpression, xenograft
LRRK2Parkinson's diseaseKnock-in mouse, patient iPSC-derived neurons
HMGB1PsoriasisKeratinocyte-specific knockout, skin inflammation models
Cancer Chemoresistance
Positive regulation of macroautophagy can promote chemoresistance in cancer cells. In colorectal cancer, HMBOX1 reverses autophagy-mediated 5-fluorouracil resistance by promoting HACE1-induced ubiquitination and degradation of ATG5. In osteosarcoma, the COPS3-FOXO3 positive feedback loop enhances autophagy and cisplatin resistance. These findings suggest that targeting autophagy activation may sensitize tumors to chemotherapy.
Metabolic and Inflammatory Diseases
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation, highlighting the protective role of autophagy activation in metabolic liver disease. In psoriasis, autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in skin inflammation. Modulating autophagy may offer therapeutic benefits in these conditions.
Neurodegeneration
LRRK2 is a key player in Parkinson's disease and regulates autophagy and lysosomal function. Chaperone-mediated autophagy, a related process, is also implicated in neurodegenerative diseases. Positive regulation of macroautophagy may help clear protein aggregates and protect neurons.

From positive regulation of macroautophagy-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X positively regulate macroautophagy?CRISPR knockout cell lines, LC3 flux assays
Does a point mutation in gene X affect autophagy activation?CRISPR point mutation knock-in cells
How does gene X overexpression impact autophagy flux?CRISPR overexpression (CRISPRa) or lentiviral overexpression
What is the role of gene X in disease?Knockout mouse models, xenografts
Can gene X be targeted for therapy?Patient-derived organoids, CRISPR screening
Does gene X regulate autophagy in a tissue-specific manner?Conditional knockout mice

How to Study the positive regulation of macroautophagy Process

MethodWhat It MeasuresTypical Application
LC3 flux assayAutophagosome formation and degradationQuantify autophagy activation
CRISPR knockout screenGenes required for autophagyIdentify novel regulators
RNA-seqTranscriptional changesAutophagy gene expression profiling
ProteomicsProtein ubiquitination and degradationStudy ATG5 ubiquitination
Electron microscopyAutophagosome ultrastructureConfirm autophagy induction
GFP-LC3 punctaAutophagosome numberHigh-throughput imaging
Western blotLC3-II/LC3-I ratio, p62 levelsMonitor autophagy flux
Measuring Autophagy Flux
LC3 turnover assays, GFP-LC3 puncta formation, and autophagic flux measurements using lysosomal inhibitors are standard methods to assess positive regulation of macroautophagy. These techniques quantify the rate of autophagosome formation and degradation.
CRISPR Screening for Autophagy Regulators
Genome-wide CRISPR knockout or activation screens can identify novel positive regulators of macroautophagy. Such screens have been used to uncover genes like HMBOX1 and COPS3 that modulate autophagy and chemoresistance.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can reveal changes in autophagy-related gene expression and protein ubiquitination. For example, HMBOX1 promotes HACE1-induced ubiquitination of ATG5, which can be detected by mass spectrometry.
Imaging and Ultrastructural Analysis
Electron microscopy and fluorescence imaging visualize autophagosomes and autolysosomes. These methods are critical for confirming positive regulation of macroautophagy at the morphological level.

How CRISPR Can Be Used to Study GO:0016239 positive regulation of macroautophagy

Knockout

CRISPR knockout of positive regulators such as TXNIP, HMBOX1, or COPS3 can abolish autophagy activation and reverse disease phenotypes. For example, HMBOX1 knockout increases 5-fluorouracil resistance in colorectal cancer cells.

Point Mutation

Point mutations in autophagy genes can mimic disease-associated variants or disrupt phosphorylation sites. CRISPR point mutation knock-in models help dissect the precise molecular mechanisms of autophagy regulation.

Knock-in

Knock-in of tagged alleles (e.g., GFP-LC3) allows real-time monitoring of autophagosome dynamics. This approach is invaluable for studying positive regulation of macroautophagy in live cells.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression of genes like TXNIP or COPS3 can enhance autophagy and protect against steatohepatitis or promote chemoresistance.

How EDITGENE Supports positive regulation of macroautophagy Research

Researchers studying positive regulation of macroautophagy-related genes often need to determine whether a candidate gene is causally involved in autophagy activation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of macroautophagy research.

Frequently Asked Questions About positive regulation of macroautophagy

GO:0016239 is a Gene Ontology term describing any process that activates or increases the rate of macroautophagy, the bulk degradation of cytosolic components in lysosomes or vacuoles.
Key genes include TXNIP, HMBOX1, COPS3, FOXO3, RUBCNL/PACER, LRRK2, and SnRK1, among others.
It is activated by nutrient depletion, stress, and signaling pathways such as mTORC1 inhibition, AMPK activation, and feedback loops involving COPS3-FOXO3.
Diseases include steatohepatitis, colorectal cancer, osteosarcoma, psoriasis, and Parkinson's disease.
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of autophagy genes to assess their causal roles.
LC3 flux assays, GFP-LC3 puncta, electron microscopy, and Western blot for LC3-II are commonly used.
TXNIP promotes autophagy initiation and fatty acid oxidation, attenuating steatohepatitis.
HMBOX1 promotes HACE1-induced ubiquitination and degradation of ATG5, reversing autophagy-mediated 5-fluorouracil resistance.
It is a positive feedback loop that regulates autophagy and promotes cisplatin resistance in osteosarcoma.
Yes, EDITGENE offers genome-wide CRISPR library screening and bioinformatics to identify novel positive regulators of macroautophagy.

Conclusion

Positive regulation of macroautophagy (GO:0016239) is a fundamental cellular process with broad implications for health and disease. Understanding its molecular mechanisms and key regulators can lead to new therapeutic strategies for cancer, metabolic disorders, and neurodegeneration. EDITGENE provides the CRISPR tools and services needed to dissect this pathway and accelerate discovery.

References

  1. 1. Park HS et al.. 2021. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.. Autophagy 17(9):2549-2564 PMID: 33190588
  2. 2. Yao R et al.. 2023. Chaperone-mediated autophagy: Molecular mechanisms, biological functions, and diseases.. MedComm (2020) 4(5):e347 PMID: 37655052
  3. 3. Yang C et al.. 2023. Autophagy contributes to positive feedback regulation of SnRK1 signaling in plants.. Autophagy 19(12):3248-3250 PMID: 37584544
  4. 4. Gao Y et al.. 2025. HMBOX1 reverses autophagy mediated 5-fluorouracil resistance through promoting HACE1-induced ubiquitination and degradation of ATG5 in colorectal cancer.. Autophagy 21(7):1556-1577 PMID: 40126194
  5. 5. Wang Z et al.. 2021. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.. Autophagy 17(2):529-552 PMID: 32019420
  6. 6. Rojas-Rivera D et al.. 2024. The autophagy protein RUBCNL/PACER represses RIPK1 kinase-dependent apoptosis and necroptosis.. Autophagy 20(11):2444-2459 PMID: 38873940
  7. 7. Manzoni C et al.. 2017. LRRK2 and Autophagy.. Adv Neurobiol 14:89-105 PMID: 28353280
  8. 8. Niu J et al.. 2023. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.. Autophagy 19(6):1693-1710 PMID: 36451342
Contact Us
*
*
*
*
How did you hear about us: